TrialBMC infectious diseases2014

Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older.

Robert B Couch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.